Healthspan podcast

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

7/10/2024
0:00
11:00
Manda indietro di 15 secondi
Manda avanti di 15 secondi

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

Altri episodi di "Healthspan"